Comparing Body Composition Methods for Air Force Reserve Officers' Training Corps Cadets von Naylor, Trey R, Kiss, Jessica E, Fullenkamp, Adam M, Garon, David K

Volltext

Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy von Chowell, Diego, Morris, Luc G T, Grigg, Claud M, Weber, Jeffrey K, Samstein, Robert M, Makarov, Vladimir, Kuo, Fengshen, Kendall, Sviatoslav M, Requena, David, Riaz, Nadeem, Greenbaum, Benjamin, Carroll, James, Garon, Edward, Hyman, David M, Zehir, Ahmet, Solit, David, Berger, Michael, Zhou, Ruhong, Rizvi, Naiyer A, Chan, Timothy A

Volltext

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Be... von PATEL, Jyoti D, SOCINSKI, Mark A, GUBA, Susan C, JINGYI LIU, FRIMODT-MOLLER, Bente, JOHN, William J, OBASAJU, Coleman K, PENNELLA, Eduardo J, BONOMI, Philip, GOVINDAN, Ramaswamy, GARON, Edward B, REYNOLDS, Craig H, SPIGEL, David R, OLSEN, Mark R, HERMANN, Robert C, JOTTE, Robert M, BECK, Thaddeus, RICHARDS, Donald A

Volltext

Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC von Tumeh, Paul C, Hellmann, Matthew D, Hamid, Omid, Tsai, Katy K, Loo, Kimberly L, Gubens, Matthew A, Rosenblum, Michael, Harview, Christina L, Taube, Janis M, Handley, Nathan, Khurana, Neharika, Nosrati, Adi, Krummel, Matthew F, Tucker, Andrew, Sosa, Eduardo V, Sanchez, Phillip J, Banayan, Nooriel, Osorio, Juan C, Nguyen-Kim, Dan L, Chang, Jeremy, Shintaku, I Peter, Boasberg, Peter D, Taylor, Emma J, Munster, Pamela N, Algazi, Alain P, Chmielowski, Bartosz, Dummer, Reinhard, Grogan, Tristan R, Elashoff, David, Hwang, Jimmy, Goldinger, Simone M, Garon, Edward B, Pierce, Robert H, Daud, Adil

Volltext

Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer von Hu-Lieskovan, Siwen, Lisberg, Aaron, Zaretsky, Jesse M, Grogan, Tristan R, Rizvi, Hira, Wells, Daniel K, Carroll, James, Cummings, Amy, Madrigal, John, Jones, Benjamin, Gukasyan, Jacklin, Shintaku, I Peter, Slamon, Dennis, Dubinett, Steven, Goldman, Jonathan W, Elashoff, David, Hellmann, Matthew D, Ribas, Antoni, Garon, Edward B

Volltext

High-definition tDCS of the temporo-parietal cortex enhances access to newly learned words von Perceval, Garon, Martin, Andrew K., Copland, David A., Laine, Matti, Meinzer, Marcus

Volltext

Multisession transcranial direct current stimulation facilitates verbal learning and memory consolidation in young and older adults von Perceval, Garon, Martin, Andrew K., Copland, David A., Laine, Matti, Meinzer, Marcus

Volltext

Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients von Brahmer, Julie R., Long, Georgina V., Hamid, Omid, Garon, Edward B., Herbst, Roy S., Andre, Thierry, Armand, Philippe, Bajorin, Dean, Bellmunt, Joaquim, Burtness, Barbara, Choueiri, Toni K., Cohen, Ezra E.W., Diaz, Luis A., Shitara, Kohei, Kulkarni, Girish, McDermott, David, Shah, Manish, Tabernero, Josep, Vogel, Arndt, Zinzani, Pier Luigi, Jafari, Niusha, Bird, Steven, Snyder, Ellen, Gause, Christine, Bracco, Oswaldo L., Pietanza, M. Catherine, Gruber, Todd, Ribas, Antoni

Volltext

Global effects of land use on local terrestrial biodiversity von Newbold, Tim, Hudson, Lawrence N., Hill, Samantha L. L., Contu, Sara, Lysenko, Igor, Senior, Rebecca A., Börger, Luca, Bennett, Dominic J., Choimes, Argyrios, Collen, Ben, Day, Julie, De Palma, Adriana, Díaz, Sandra, Echeverria-Londoño, Susy, Edgar, Melanie J., Feldman, Anat, Garon, Morgan, Harrison, Michelle L. K., Alhusseini, Tamera, Ingram, Daniel J., Itescu, Yuval, Kattge, Jens, Kemp, Victoria, Kirkpatrick, Lucinda, Kleyer, Michael, Correia, David Laginha Pinto, Martin, Callum D., Meiri, Shai, Novosolov, Maria, Pan, Yuan, Phillips, Helen R. P., Purves, Drew W., Robinson, Alexandra, Simpson, Jake, Tuck, Sean L., Weiher, Evan, White, Hannah J., Ewers, Robert M., Mace, Georgina M., Scharlemann, Jörn P. W., Purvis, Andy

Volltext

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer von Borghaei, H, de Marinis, F, Dumoulin, D, Reynolds, C, Theelen, W S M E, Percent, I, Gutierrez Calderon, V, Johnson, M L, Madroszyk-Flandin, A, Garon, E B, He, K, Planchard, D, Reck, M, Popat, S, Herbst, R S, Leal, T A, Shazer, R L, Yan, X, Harrigan, R, Peters, S

Volltext

EVOKE-02: A phase 2 study of sacituzumab govitecan (SG) plus pembrolizumab (pembro) with or without platinum chemotherapy in first-line metastatic non–small cell lung cancer (NSCLC... von Garon, Edward B., Liu, Stephen V., Owen, Scott Peter, Reck, Martin, Neal, Joel W., Vicente, David, Mekan, Sabeen Fatima, Safavi, Farnoush, Fernando, Nelumka, Mok, Tony S. K.

Volltext

Phase 2 Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin with Concurrent Radiation Therapy Followed by Pemetrexed Consolidation in Patients with Favorable-Prognos... von Choy, Hak, Schwartzberg, Lee S., Dakhil, Shaker R., Garon, Edward B., Gerber, David E., Choksi, Janak K., Govindan, Ramaswamy, Peng, Guangbin, Koustenis, Andrew, Treat, Joseph, Obasaju, Coleman

Volltext

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors von Araujo, Haniel A., Do, Minh Truong, Qian, Yu, Sun, Xin, Montesion, Meagan, Palmer, Rachael, Jahchan, Nadine, Juan, Joseph M., Min, Chengyin, Yu, Yi, Pan, Xuewen, Arbour, Kathryn C., Vokes, Natalie, Molkentine, David, Owen, Dwight H., Memmott, Regan, Patil, Pradnya D., Marmarelis, Melina E., Awad, Mark M., Murray, Joseph C., Hellyer, Jessica A., Gainor, Justin F., Dimou, Anastasios, Bestvina, Christine M., Shu, Catherine A., Riess, Jonathan W., Blakely, Collin M., Mezquita, Laura, Tabbó, Fabrizio, Scheffler, Matthias, Digumarthy, Subba, Sacher, Adrian G., Lau, Sally C. M., Saltos, Andreas N., Rotow, Julia, Johnson, Rocio Perez, Liu, Corinne, Stewart, Tyler, Goldberg, Sarah B., Killam, Jonathan, Walther, Zenta, Schalper, Kurt, Davies, Kurtis D., Anagnostou, Valsamo, Marrone, Kristen A., Forde, Patrick M., Ricciuti, Biagio, Venkatraman, Deepti, Goldman, Jonathan W., Shaish, Hiram, Katz, Sharyn, Azok, Joseph T., Segal, Jeremy, Neal, Joel W., Lacroix, Ludovic, Elamin, Yasir Y., Negrao, Marcelo V., Le, Xiuning, Lam, Vincent K., Lewis, Whitney E., Carter, Brett, Roth, Jack A., Swisher, Stephen, Zhou, Teng, Poteete, Alissa, Kong, Yifan, Takehara, Tomohiro, Paula, Alvaro Guimaraes, Parra Cuentas, Edwin R., Blumenschein, George R., Byers, Lauren A., Gibbons, Don L., Tsao, Anne, Bivona, Trever G., Lieghl, Natasha, Levy, Benjamin, Brahmer, Julie R., Garassino, Marina C., Gandara, David R., Rizvi, Naiyer A., Scagliotti, Giorgio Vittorio, Wolf, Jürgen, Planchard, David, Besse, Benjamin, Wakelee, Heather A., Pennell, Nathan A., Shaw, Alice T., Jänne, Pasi A., Rudin, Charles M., Albacker, Lee, Mann, Helen, Lai, Zhongwu, Peters, Solange, Wong, Kwok K., Huang, Alan, Winslow, Monte M., Winters, Ian P., Papadimitrakopoulou, Vassiliki A., Cascone, Tina, Jewsbury, Philip

Volltext

Long-Term In vitro Cultivation of Plasmodium falciparum in a Novel Cell Culture Device von Géry, Antoine, Basco, Leonardo K, Heutte, Natacha, Guillamin, Marilyne, N’guyen, Ho-Mai-Thy, Richard, Estelle, Garon, David, Eldin de Pécoulas, Philippe

Volltext

Long-Term In vitro Cultivation of Plasmodium falciparum in a Novel Cell Culture Device von Géry, Antoine, Basco, Leonardo K, Heutte, Natacha, Guillamin, Marilyne, N’guyen, Ho-Mai-Thy, Richard, Estelle, Garon, David, Eldin de Pécoulas, Philippe

Volltext

PS01.59: CheckMate 370: A Master Protocol of Phase 1/2 Studies of Nivolumab as Maintenance or First-Line ± Standard-of-Care Therapies in Advanced NSCLC: Topic: Medical Oncology von Blumenschein, George, Chandler, Jason, Garon, Edward B., Waterhouse, David, Goldman, Jonathan W., Gunuganti, Vijay K., Boccia, Ralph, Spigel, David, Glaspy, John, Berry, Donald A., Korytowsky, Beata, Zhu, Jin, Lin, Wen Hong, Bennett, Kelly, Reynolds, Craig

Volltext

Long-Term In vitro Cultivation of Plasmodium falciparum in a Novel Cell Culture Device von Géry, Antoine, Basco, Leonardo K, Heutte, Natacha, Guillamin, Marilyne, N'Guyen, Ho-Mai-Thy, Richard, Estelle, Garon, David, Eldin de Pécoulas, Philippe

Volltext

CheckMate 384: Phase IIIb/IV trial of nivolumab (nivo) 480 mg Q4W versus 240 mg Q2W after ≤ 12 months of nivo in previously treated advanced NSCLC von Garon, Edward B., Reinmuth, Niels, Falchero, Lionel, Garcia Garcia, Yolanda, Hureaux, José, Gore, Ira, Harris, Ronald P., Bidoli, Paolo, Baldini, Editta, Ros, Silverio, Laack, Eckart, Mitchell, Paul, Wolf, Martin, O'Byrne, Kenneth John, Zibdawi, Labib, Jao, Kevin, Spigel, David, Li, Ang, Rabindran, Sridhar K., Pichon, Eric

Volltext

Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carb... von Reynolds, Craig H, Patel, Jyoti D, Garon, Edward B, Olsen, Mark R, Bonomi, Philip, Govindan, Ramaswamy, Pennella, Eduardo J, Liu, Jingyi, Guba, Susan C, Li, Shi, Spigel, David R, Hermann, Robert C, Socinski, Mark A, Obasaju, Coleman K

Volltext

PS01.59: CheckMate 370: A Master Protocol of Phase 1/2 Studies of Nivolumab as Maintenance or First-Line ± Standard-of-Care Therapies in Advanced NSCLC von Blumenschein, George, Chandler, Jason, Garon, Edward B., Waterhouse, David, Goldman, Jonathan W., Gunuganti, Vijay K., Boccia, Ralph, Spigel, David, Glaspy, John, Berry, Donald A., Korytowsky, Beata, Zhu, Jin, Lin, Wen Hong, Bennett, Kelly, Reynolds, Craig

Volltext